会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明申请
    • Hollow Reflecting Optical Element and Scanning Optical Device
    • 中空反射光学元件和扫描光学器件
    • US20120008184A1
    • 2012-01-12
    • US13257546
    • 2010-02-04
    • Shinichiro HaraNaoki KanekoHiroshi Takagi
    • Shinichiro HaraNaoki KanekoHiroshi Takagi
    • G02B26/12G02B5/08
    • G02B26/126B29C45/1704B29C45/7613B29C45/762B29C2945/76167B29C2945/76257B29C2945/76381B29C2945/76411B29C2945/76454B29C2945/76474B29C2945/76488B29C2945/76585B29C2945/76943B29D11/00596B29L2011/0058B41J2/471G02B27/0031
    • Provided are a resinous reflecting optical element that achieves high mirror surface precision by mitigating the warping effects associated with contraction during resin hardening and suppressing the distortion of a mirror surface that results from resistance to mold release, and a scanning optical device that uses said reflecting optical element. The reflecting optical element is characterized by having a long, tabular substrate (3), a mirror surface section (2) positioned on one surface of the substrate (3), and a hollow portion (4) positioned within the interior of the substrate (3), and is also characterized in that, as a result of configuring so that the hollow portion (4) is longer than the mirror surface section (2), warping and sink marks which form due to contraction during resin hardening are mitigated across the entire mirror surface section (2), and in that the entire mirror surface section (2) protrudes above the surface of the substrate (3), thereby suppressing the increase in resistance to mold release that occurs when a metallic mold is gripped by the molding during resin contraction, and preventing distortion of the mirror surface section (2) that is caused by resistance to mold release.
    • 提供一种树脂反射光学元件,其通过减轻与树脂硬化期间的收缩相关的翘曲效应并抑制由于抵抗脱模导致的反射镜表面的变形而实现高镜面精度;以及扫描光学装置,其使用所述反射光学 元件。 反射光学元件的特征在于具有长的平板状基板(3),位于基板(3)的一个表面上的镜面部分(2)和位于基板内部的中空部分(4) 3),其特征还在于,通过构造使得中空部分(4)比镜面部分(2)长,由于在树脂硬化期间由于收缩而形成的翘曲和凹痕被缓和 整个镜面部分(2),并且整个镜面部分(2)突出在基底(3)的表面上方,从而抑制当通过模制夹持金属模具时发生的抗脱模性的增加 在树脂收缩期间,并且防止由于抵抗脱模而引起的镜面部分(2)的变形。
    • 72. 发明申请
    • REGISTRATION TERMINAL, SETTLEMENT TERMINAL, TRANSACTION CONTENT CHANGING METHOD, AND COMMODITY SALES PROCESSING APPARATUS
    • 注册终端,结算终端,交易内容变更方法和商品销售处理设备
    • US20110055031A1
    • 2011-03-03
    • US12873571
    • 2010-09-01
    • Hiroshi Takagi
    • Hiroshi Takagi
    • G06Q30/00
    • G06Q20/20G06Q30/06
    • According to one embodiment, a registration terminal includes: a connecting unit connected to a settlement terminal, the settlement terminal being configured to store sales data indicating transaction content of a transaction for purchase of a commodity transmitted from the outside and execute processing concerning settlement of the transaction on the basis of the stored sales data; a generating unit configured to generate, every time the transaction is performed, sales data indicating content of the transaction; a registering unit configured to transmit the sales data generated by the generating unit to the settlement terminal; a readout requesting unit configured to request the settlement terminal to read out the sales data stored in the settlement terminal; and a changing unit configured to change the transaction content of the sales data read out from the settlement terminal and transmit the sales data after the change to the settlement terminal as sales data for update.
    • 根据一个实施例,登记终端包括:连接到结算终端的连接单元,结算终端被配置为存储指示用于购买从外部发送的商品的交易的交易内容的销售数据,并且执行涉及到的结算的处理 在存储的销售数据的基础上进行交易; 生成单元,被配置为在每次执行交易时生成指示交易内容的销售数据; 注册单元,被配置为将生成单元生成的销售数据发送给结算终端; 读出请求单元,被配置为请求结算终端读出存储在结算终端中的销售数据; 以及改变单元,被配置为改变从结算终端读出的销售数据的交易内容,并将更改之后的销售数据作为销售数据发送到结算终端作为更新。
    • 73. 发明授权
    • Lactam ring-opening enzyme and use thereof
    • 内酰胺开环酶及其用途
    • US07892784B2
    • 2011-02-22
    • US11710612
    • 2007-02-26
    • Hiroshi TakagiYoshimitsu Hamano
    • Hiroshi TakagiYoshimitsu Hamano
    • C12P1/00C12P17/00C12P17/16C12P15/00
    • C12N9/86C12P19/28
    • An enzyme capable of reducing the antibiotic activity (i.e., toxicity) of streptothricin with respect to eukaryotic cells without sacrificing antibiotic activity with respect to prokaryotic cells is provided along with a streptothricin derivative having reduced toxicity with respect to eukaryotic cells while retaining antibiotic activity with respect to prokaryotic cells, and a manufacturing method thereof. By opening the lactam ring of streptothricin, a protein having the amino acid sequence according to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14 or 16 of the invention can reduce the antibiotic activity of streptothricin D with respect to eukaryotic cells without sacrificing antibiotic activity with respect to prokaryotic cells.
    • 提供能够降低链霉素相对于真核细胞的抗生素活性(即毒性)而不牺牲相对于原核细胞的抗生素活性的酶以及相对于真核细胞毒性降低的链球菌素衍生物,同时保持抗生素活性 原核细胞及其制造方法。 通过打开链霉素的内酰胺环,具有根据本发明的SEQ ID NO:2,4,6,8,10,12,14或16的氨基酸序列的蛋白质可以降低链球菌D的抗生素活性,相对于 真核细胞,而不牺牲相对于原核细胞的抗生素活性。
    • 77. 发明授权
    • Physiologically active peptides
    • 生理活性肽
    • US07329726B2
    • 2008-02-12
    • US11010800
    • 2004-12-13
    • Shigeru NakamoriHiroshi TakagiMasakazu TakahashiKazuhisa TsujimotoHideyuki Yamada
    • Shigeru NakamoriHiroshi TakagiMasakazu TakahashiKazuhisa TsujimotoHideyuki Yamada
    • C07K7/06A61K38/08C12N5/02
    • C07K14/43586C12N5/0018C12N5/0601C12N2501/998C12N2501/999
    • A peptide according to the present invention is selected from the group consisting of: (a) a peptide having the amino acid sequence represented by SEQ ID NO: 1; (b) a peptide having a modified amino acid sequence of the amino acid sequence described in (a) above, in which one or more amino acid residues are deleted, substituted, inserted or added, and having cell death-preventing activity and/or cell growth-promoting activity; and (c) a peptide which has an amino acid sequence having at least 80% homology with the peptide consisting of the amino acid sequence described in (a) above and has cell death-preventing activity and/or cell growth-promoting activity. The peptide has cell death-preventing activity and/or cell growth-promoting activity, is highly safe, and can be produced without difficulty. The peptide is useful as a culture supplement or as an effective component for a cell culture medium.
    • 根据本发明的肽选自:(a)具有由SEQ ID NO:1表示的氨基酸序列的肽; (b)具有上述(a)中所述的氨基酸序列的修饰氨基酸序列的肽,其中一个或多个氨基酸残基被缺失,取代,插入或添加并具有细胞死亡预防活性和/或 细胞生长促进活性; 和(c)具有与由上述(a)中所述的氨基酸序列组成的肽具有至少80%同源性的氨基酸序列并具有细胞死亡预防活性和/或细胞生长促进活性的肽。 肽具有细胞死亡预防活性和/或细胞生长促进活性,是高度安全的,可以毫无困难地制备。 该肽可用作培养物补充物或作为细胞培养基的有效成分。